Abstract | BACKGROUND: In vivo proton magnetic resonance spectroscopy is a safe and noninvasive tool that can be used to study aspects of brain chemistry and metabolism. This study was designed to evaluate its role in routine application to reveal the diagnostic reasons for cognitive impairment. METHOD: 37 Alzheimer's disease patients (NINCDS-ADRDA criteria), 31 patients with subcortical ischemic vascular dementia (Chui et al. criteria), and 13 subjects with subjective cognitive impairment (DSM-IV criteria) were included in this retrospective study. Magnetic resonance images were used for atrophy rating; additionally, proton magnetic resonance spectroscopy was performed. RESULTS: CONCLUSION:
|
Authors | Ulrike Weiss, Reinhard Bacher, Herbert Vonbank, Georg Kemmler, Albert Lingg, Josef Marksteiner |
Journal | The Journal of clinical psychiatry
(J Clin Psychiatry)
Vol. 64
Issue 3
Pg. 235-42
(Mar 2003)
ISSN: 0160-6689 [Print] United States |
PMID | 12716263
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Aspartic Acid
- Inositol
- N-acetylaspartate
- Creatine
- Choline
|
Topics |
- Aged
- Alzheimer Disease
(diagnosis, metabolism)
- Aspartic Acid
(analogs & derivatives, metabolism)
- Brain
(metabolism)
- Brain Chemistry
- Choline
(metabolism)
- Cognition Disorders
(diagnosis, metabolism)
- Creatine
(metabolism)
- Dementia
(diagnosis, metabolism)
- Dementia, Vascular
(diagnosis, metabolism)
- Diagnosis, Differential
- Female
- Humans
- Inositol
(metabolism)
- Magnetic Resonance Imaging
(methods)
- Magnetic Resonance Spectroscopy
- Male
- Memory Disorders
(diagnosis, metabolism)
- Pick Disease of the Brain
(diagnosis, metabolism)
- Retrospective Studies
- Temporal Lobe
(metabolism)
|